SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-025654
Filing Date
2022-09-28
Accepted
2022-09-28 20:50:12
Documents
1
Period of Report
2022-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166441259587540.html 3  
1 FORM 3 wf-form3_166441259587540.xml 3 3063
  Complete submission text file 0001628280-22-025654.txt   4746
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Reporting) CIK: 0001689813 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41477 | Film No.: 221277558
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Issuer) CIK: 0001935979 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations